Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients
Clinical trial NCT05400915 · COMPLETED
Trial details
- NCT number
- NCT05400915
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-23
- Primary completion
- 2021-12-13
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.